![Carl Mauch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Mauch
Contatto Relazioni con gli Investitori presso
TCR2 THERAPEUTICS INC.
Profilo
Carl F.
Mauch is currently Director at Stern Investor Relations, Inc. since 2016.
Mr. Mauch is also Investor Relations & Media Contact at TCR² Therapeutics, Inc. Mr. Mauch will be Head-Media & Investor Relations at Vor Biopharma, Inc. starting in 2025.
Formerly, Mr. Mauch was Investor Relations & Media Contact at iTeos Therapeutics, Inc.
Posizioni attive di Carl Mauch
| Società | Posizione | Inizio |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | - |
| VOR BIOPHARMA INC. | Contatto Relazioni con gli Investitori | 01/01/2025 |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Direttore/Membro del Consiglio | 01/01/2016 |
Precedenti posizioni note di Carl Mauch
| Società | Posizione | Fine |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
53
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Finance |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
